Introduction: During stress echocardiography, the echocardiologist routinely collects both echocardiographic images and stress electrocardiogram (ECG) concurrently. The managing physician faces a dilemma when the stress ECG and stress echocardiography results are discordant; for example, when a patient has negative stress echocardiography but positive stress ECG. We therefore sought to evaluate the prognostic value of stress echocardiography in relation to concordant or discordant stress ECG findings in our local Singapore setting, which has a well-defined Southeast Asian population.
INTRODUCTION
Positive stress echocardiography is associated with a threefold increased incidence of a cardiac event and a fourfold increased incidence of myocardial infarction within 12 months of follow-up when compared with negative stress echocardiography. (1) During stress echocardiography, the echocardiologist routinely collects both echocardiographic images and stress electrocardiogram (ECG) concurrently. The managing physician faces a dilemma when the stress ECG and stress echocardiography results are discordant (e.g. when a patient has negative stress echocardiography but positive stress ECG). A positive stress ECG could indicate a high risk of imminent cardiac event whereas negative stress echocardiography would indicate the contrary. (2) However, Kobal et al (3) and Mahenthiran et al (4) have demonstrated, in their studies, that a normal finding on stress echocardiography confers a benign prognosis independent of the type of stress ECG response during stress studies. (3, 4) We therefore sought to evaluate the prognostic value of stress echocardiography in relation to concordant or discordant stress ECG findings in our local Singapore setting, which has a well-defined Southeast Asian multiethnic population.
METHODS
We conducted a retrospective observational study of all patients who underwent stress echocardiography in 2012 at Changi General Hospital (CGH), Singapore. CGH is a 1,000bed tertiary hospital in eastern Singapore, serving a population of 1.6 million people. The study was approved by the local institutional review board. All study patients were followed up for 18 months via electronic medical records using the Singapore National Electronic Health Record system.
A resting echocardiogram was performed in the lateral decubitus position. Resting digital images, with tissue harmonic imaging of the left ventricle, were obtained in the parasternal long-axis, short-axis, and apical four-and two-chamber views using iE 33 xMATRIX echocardiography system (Koninklijke Philips, Eindhoven, Netherlands) or Vivid E9 echocardiography system (GE Healthcare, Chicago, IL, USA).
Exercise stress echocardiography images were acquired immediately (within 90 seconds) after peak exercise. Immediate post-exercise images, with the best endocardial definition, were selected and displayed alongside the corresponding baseline images.
Exercise testing was symptom-limited and was stopped for standard criteria as follows: moderate-to-severe chest pain; fatigue; shortness of breath; and significant arrhythmia. The patients were expected to achieve target heart rate defined as > 85% maximal age-predicted heart rate. Failure to achieve the target heart rate was defined as submaximal exercise testing and these patients were not to be included in the data analysis. For patients who were not able to perform the treadmill exercise, pharmacologic stress testing with dobutamine infusion was administered instead, according to American Society of Echocardiography 2007 guidelines. (5) A graded dobutamine infusion starting at 5 g/kg/minute and increasing at 3-minute intervals to 10 g/kg/minute, 20 g/kg/minute, 30 g/kg/minute and 40 g/kg/minute was the standard for dobutamine stress testing. Atropine in divided doses of 0.3 mg to a total of 2.4 mg would be used, as needed, to achieve the target heart rate. Endpoints were achievement of target heart rate, new or worsening wall motion abnormalities of moderate degree, significant arrhythmias, hypotension, severe hypertension, and intolerable symptoms. Function in each segment was graded at rest and with stress as normal or hyperdynamic, hypokinetic, akinetic, dyskinetic or aneurysmal. Images from low or intermediate stages of dobutamine infusion were compared with peak stress images to maximise the sensitivity for detection of coronary disease.
In technically difficult patients, with two or more left ventricular segments not adequately visualised at rest or during deep breathing, intravenous contrast (Sonovue; Bracco, Milan, Italy) was used to enhance endocardial border definition. Bolus injections of 0.3-0.5 mL were administered through a peripheral cannula followed by a slow flush with normal saline solution.
Online digital images were interpreted qualitatively for the presence, extent and location of regional wall motion abnormalities by the performing echocardiologist as per routine clinical practice. A normal stress echocardiogram result was defined as normal left ventricle wall motion at rest and with stress. Resting wall motion abnormalities, unchanged with stress, were classified as 'fixed' and most often represented regions of prior infarction.
This group would still be classified as negative for inducible ischaemia. Only abnormal study findings for those with new or worsening wall motion abnormalities were classified as positive for inducible ischaemia. Patients with uninterpretable images or patients who failed to achieve the target heart rate were considered to have an inconclusive test.
Stress electrocardiography was performed concurrently during stress echocardiography by experienced cardiac physiologists. Tests were reported as negative, positive, borderline or inconclusive for ischaemia according to predetermined parameters by the performing echocardiologist. Stress ECG results were defined as positive (ischaemic) if there was ≥ 1 mm ST-segment depression 0.08 seconds after the J point, and it was present in at least three consecutive beats in at least two contiguous leads during peak stress.
Demographics and clinical characteristics of all patients who underwent stress echocardiography were compared using one-way analysis of variance (ANOVA) for numerical variables, and chi-square test or Fisher's exact test for categorical variables, wherever appropriate. If statistically significant differences were found in ANOVA, Bonferroni post-hoc adjustment was used for multiple pairwise comparisons. Outcomes at 18 months were analysed using a logistic regression model, including the following potential confounding covariates: age; gender; ethnicity; previous history of ischaemic heart disease; previous coronary artery bypass grafting (CABG); diabetes mellitus; hypertension; and hyperlipidaemia; and usage of medications, including aspirin, clopidogrel and -blockers, angiotensin converting enzyme inhibitor (ACEI), or angiotensin II receptor blocker (ARB).
The endpoints analysed were all-cause mortality and major adverse cardiovascular events (MACE), defined as non-fatal myocardial infarction and coronary revascularisation, including percutaneous coronary intervention and coronary artery bypass grafting. Two-tailed p < 0.05 was considered to be statistically significant. Statistical analysis was performed using IBM SPSS Statistics version 19.0 (IBM Corp, Armonk, NY, USA).
RESULTS
We performed stress echocardiography for a total of 914 patients in 2012. Of these, 13 patients were excluded from analysis due to non-interpretable stress ECG findings, inconclusive stress echocardiography results due to submaximal target heart rate achieved or incomplete clinical patient information. Fig. 1 shows a flow diagram of patient recruitment into the study.
Primary outcome measurements were MACE (including all-cause and cardiovascular mortality), non-fatal myocardial infarction and coronary revascularisation (including percutaneous coronary intervention [PCI] and CABG). Secondary outcomes included either all-cause mortality and/or coronary revascularisation defined as PCI or CABG surgery. Fig. 2 shows the incidence of mortality, myocardial infarction and coronary revascularisation among recruited patients. Overall, 798 of 901 (88.6%) patients had negative endpoints.
Baseline characteristics for the four patient groups A-D are listed in Table I . Patients with abnormal stress echocardiography were older, had fewer women patients and were more likely to have more than one comorbidity (e.g. hypertension, hyperlipidaemia or diabetes mellitus). A larger number of patients had prior history of ischaemic heart disease or CABG, and were already on aspirin, clopidogrel and either ACEI, ARB or -blocker. *Data presented as mean ± standard deviation. †Bonferroni post-hoc test showed that significance with respect to age existed between the Echo+ and ECG− (Group B) and both positive (Group D) groups, which had older patients than and both negative (Group A) group (p = 0.006 and p = 0.029, respectively). Echo+ and ECG− group (Group B) was also significantly older than Echo-and ECG+ (Group C) (p = 0.023). Other comparisons were not statistically significant. ‡Included hypertension, hyperlipidaemia and diabetes mellitus. ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin II receptor blocker; CABG: coronary artery bypass grafting; ECG−: negative stress electrocardiogram; ECG+: positive stress electrocardiogram; Echo−: negative stress echocardiography; Echo+: positive stress echocardiography; IHD: ischaemic heart disease There was no difference in MACE outcomes (Table IV) (Table IV) was the strongest predictor of primary outcome, with OR at 45.39 for patients with negative stress ECG (i.e. Group B; 95% CI 22.09-93.28, p < 0.001); and OR at 35.48 for patients with positive stress ECG (i.e. Group D; 95% CI 18.44-68.26, p < 0.001). Of note, positive stress echocardiography and stress ECG (Group D) was the only variable that predicted mortality for the next 18 months (OR 4.54, 95% CI 1.18-15.70, p = 0.028) (Table III) 
DISCUSSION
To our knowledge, this was one of few studies to have compared the characteristics and clinical outcomes of a well-defined cohort of patients who had undergone stress echocardiography. Data regarding the prognostic significance of abnormal stress echocardiography has been well demonstrated in several studies. (6) (7) (8) (9) (10) (11) (12) Our study has also consistently demonstrated that patients with positive stress echocardiography, regardless of stress ECG findings, will have higher risk of developing MACE (OR 20.78, p < 0.001). Of note, patients with more than one of the following comorbidities, such as hypertension, hyperlipidaemia or diabetes mellitus (OR 3.69, p = 0.024) were at a higher risk of developing MACE.
There is scarcity of data describing overall mortality and cardiac events subsequent to normal stress echocardiography. McCully et al (13) For our study, we found that the 18-month negative predictive value for MACE in patients with normal stress echocardiography was high and unaffected by the type of stress ECG response (95.8% and 92.6% for patients with negative stress ECGs and positive stress ECGs, respectively). Kobal et al (3) and Mahenthiran et al (4) had similarly demonstrated in their previous studies that a normal wall motion response, even in the setting of an ischaemic (positive) stress ECG response, portends a benign prognosis for patients undergoing stress echocardiography.
In our study, there was a 15.4% incidence of positive stress ECG response among patients with normal stress echocardiography findings. This was not unexpected given the fact that the reported specificity of exercise electrocardiographic treadmill test, i.e. stress ECG, for diagnosing ischaemic heart disease was 77%. (14, 15) This study was not without limitations. This was a retrospective cohort study that followed up patients for 18 months from the test date. Patients in our database are still being followed for analysis of results over a longer period of time. The study was conducted at a single centre. However, the patient population attended to by CGH is representative of the ethnic make-up of Singapore and Southeast Asia, in general. Stress echocardiography images were all captured and interpreted by various echocardiologists who were on duty and this could have resulted in inter-rater variability. However, this could possibly be viewed positively, as it replicates real-life situations, wherein stress echocardiography is generally performed by echocardiologists on duty at healthcare centres instead of single operators at a core echocardiography laboratory. 
